Search Results
Dec 04, 2025, 17:40 ET MDA SPACE ANNOUNCES OFFERING OF C$250 MILLION SENIOR UNSECURED NOTES DUE 2030
vision into an achievable mission – bringing to bear a one-of-a-kind mix of experience, engineering excellence and wide-eyed wonder that's been in our DNA since day one. For those who dream big and push boundaries on the ground and in the stars to change the world for the better, we'll take you there. For
More news about: MDA Space
Dec 04, 2025, 16:54 ET Human Longevity Expands $1M Cancer Pledge to Redefine Early Detection and Prevention of Colon Cancer
approach was demonstrated by a recent client experience. The patient had a normal colonoscopy, yet both the GRAIL blood test and the Cologuard stool DNA test returned positive results. Follow-up evaluation revealed cancer in the appendix, a region near the colon not always fully evaluated during routine
More news about: Human Longevity, Inc.
Dec 04, 2025, 15:17 ET AlidaBio Introduces the EpiPlex™ Duo-Mod™ Service for Concurrent m6A and Inosine Mapping with Integrated RNA Expression Profiling
revealing immune dysregulation in autoimmune disease, early oncogenic signaling, and RNA misprocessing in neurodegeneration, insights often missed by DNA, RNA expression, or protein analyses alone.The EpiPlex Duo-Mod Service applies AlidaBio's proximity barcoding and enrichment chemistry to profile
More news about: Alida Biosciences
Dec 04, 2025, 12:04 ET CASIS to Manage the International Space Station National Laboratory Through 2030
the next generation of researchers, engineers, and explorers. For example, the annual Genes in Space™ research competition launches student-designed DNA experiments to the space station, and these projects have
More news about: International Space Station National Lab
Dec 04, 2025, 12:00 ET Dessert Holdings Partners with Synoptek to Drive Digital Transformation and Growth
and Platform Development, Customer and Employee Experience, and Cybersecurity. With growth, ownership, inclusiveness, and philanthropy embedded in its DNA, Synoptek is committed to delivering improved business results and unmatched service to all its stakeholders.
More news about: Synoptek
Dec 04, 2025, 10:00 ET Southern Arizona Survey Shows Strong Support for Copper Mining and Workforce Education
the University of Arizona School of Mining Engineering & Mineral ResourcesAs one of the founding schools in 1885, mining is in the DNA of the University of Arizona. But the industry and the world it serves have evolved greatly since those early years. Responsible practices, health and
More news about: Arizona Mining Association
Dec 04, 2025, 09:05 ET MDA SPACE AWARDED INITIAL CONTRACT BY CANADIAN SPACE AGENCY FOR RADARSAT CONSTELLATION MISSION REPLENISHMENT SATELLITE
vision into an achievable mission – bringing to bear a one-of-a-kind mix of experience, engineering excellence and wide-eyed wonder that's been in our DNA since day one. For those who dream big and push boundaries on the ground and in the stars to change the world for the better, we'll take you there. For
More news about: MDA Space
Dec 04, 2025, 08:30 ET Powered By Innovation: Murata to Showcase Intelligent System Technologies for Mobility, Wellness, and Connectivity at CES 2026
non-invasively, continuously, and intelligently. Solutions on display include:Molecular Analysis Platform 1, 2,3 (15-minute DNA/RNA analysis)Vios Monitoring System (continuous hospital-grade telemetry and remote ECG)Application example of the 3D substrate Multilayer
More news about: Murata Electronics North America, Inc.
Dec 04, 2025, 03:53 ET Dessert Holdings Partners with Synoptek to Drive Digital Transformation and Growth
and Platform Development, Customer and Employee Experience, and Cybersecurity. With growth, ownership, inclusiveness, and philanthropy embedded in its DNA, Synoptek is committed to delivering improved business results and unmatched service to all its stakeholders.
More news about: Synoptek
Dec 03, 2025, 21:00 ET X-Design Takes #1 on Product Hunt with AI Agent That Democratizes Branding for Local Businesses
memory. It serves as an always-on brand manager, ensuring that everything from a shop's logo to its Instagram posts retains the brand's unique "Visual DNA" without requiring users to repeat themselves.Solving the "Visual Consistency" Struggle for SMBsBuilt on insights from over 500
More news about: X-Design
Dec 03, 2025, 17:31 ET Hemophilia A Market to Exhibit Growth at a CAGR of 2.9% During the Forecast Period (2025-2034) Owing to the Rising Hemophilia Prevalence, Strong Uptake of New Drugs, and Emergence of High-cost Gene Therapies | DelveInsight
A utilizing an Adeno-associated Virus (AAV) vector derived from the AAVhu37 serotype. It is a non-replicating AAV vector carrying a single-stranded DNA genome that encodes a B-domain–deleted FVIII, driven by a liver-specific promoter and enhancer sequence optimized for strong transgene expression. The
More news about: DelveInsight Business Research, LLP
Dec 03, 2025, 11:11 ET Straightforward Guide to Funding Featured in LibraryBub Selection for December
Blewett ISBN: 979-8339626329It's All about Your Team: One Team. Shared Success by Michael Giaramita ISBN: 978-1637352670Leadership DNA: shaping a thriving business culture by Alinka Rutkowska, Deepak Bhootra, Brandon C. Blewett et al. ASIN: B0CZG4GNFJNavigating B2B: master
More news about: LibraryBub
Dec 03, 2025, 11:00 ET Fin Raises $17M to Launch Stablecoin Product for High-Value Payments
crypto—simple, intuitive, and ready for real-world users," said Ryan Barney, Partner at Pantera Capital. "Fin brings that same product DNA to high-value global payments, stepping into a massive global opportunity."About Fin
More news about: Fin
Dec 03, 2025, 10:42 ET Astrin Biosciences Launches Certitude™ Breast, the First Non-Imaging Breast Cancer Detection Test
to mammograms, detecting specific signatures of cancer in women with dense breast tissue far earlier than visible on imaging or in circulating tumor DNA."I've seen firsthand how far screening has come — and where gaps remain. Mammography remains our most powerful population-level screening tool,
More news about: Astrin Biosciences
Dec 03, 2025, 10:17 ET Globant presents a new edition of Converge, its annual thought-provoking event, with global leaders sharing how to move from AI ideation to execution
technology, and human ingenuity to deliver real business outcomes. Attendees will gain actionable insights on how to embed AI into their organizations' DNA and unlock the next chapter of growth and efficiency.The agenda: learning from real-world cases and leading the changeConversations
More news about: GLOBANT
Dec 03, 2025, 09:53 ET Globant presents a new edition of Converge, its annual thought-provoking event, with global leaders sharing how to move from AI ideation to execution
technology, and human ingenuity to deliver real business outcomes. Attendees will gain actionable insights on how to embed AI into their organizations' DNA and unlock the next chapter of growth and efficiency.The agenda: learning from real-world cases and leading the change
More news about: GLOBANT
Dec 03, 2025, 09:16 ET From BlackRock to Boutique: Inflection's First Year Rewriting the Wealth Management Playbook
Inflection.Kunz firmly believes they are well-aligned for clients and the environment ahead: "Being employee-owned and grounded in single family office DNA gives us long-term alignment. It's a structure built to serve our clients for generations."Families navigating complexity, preparing for a wealth
More news about: Inflection Capital Management. LLC
Dec 03, 2025, 09:00 ET Quadriga BioSciences Announces Encouraging Interim Phase II Results of LAT1-targeted QBS72S in Breast Cancer Patients with Leptomeningeal Disease
brain barrier (BBB) as well as to selectively target numerous types of rapidly growing cancer cells. Once inside the cell QBS72S causes double-stranded DNA breaks resulting in cell death. Most aggressive cancers express high LAT1, which is commonly associated with poor prognoses.
More news about: Quadriga BioSciences, Inc.
Dec 03, 2025, 08:59 ET Vanguard Launches Target Retirement Lifetime Income Trusts
highest insurance ratings.i Updates on product design and availability will be announced throughout 2026."Lifetime income is in TIAA's DNA—the company was founded in 1918 by Andrew Carnegie specifically to provide guaranteed lifetime income to American workers," said Colbert Narcisse, Chief
More news about: Vanguard
Dec 03, 2025, 08:30 ET Foresight Diagnostics Announces Multiple Presentations in Lymphoma Featuring PhasED-Seq™ Ultrasensitive MRD Analysis at the upcoming ASH Annual Meeting
This year's presentations reflect the growing integration of highly sensitive, circulating tumor DNA (ctDNA)-based MRD testing into clinical studies across hematologic malignancies. Academic groups and pharmaceutical partners are increasingly deploying
More news about: Foresight Diagnostics, Inc.
Dec 03, 2025, 08:00 ET STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene Therapy
MV platform and expertise in bone marrow-targeted in vivo delivery. As the Prime Awardee, STRM will collaborate with Ginkgo Bioworks (NYSE: DNA), the University of British Columbia (UBC), and Advanced Bioprocess Services (ABS) to develop in vivo CAR-T therapeutics. The partnership will
More news about: STRM.BIO
Dec 03, 2025, 07:30 ET ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA® in Combination with Bispecific Antibody Supporting Potential Best-in-Class Regimen in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma
internalized by the cell, where enzymes release a pyrrolobenzodiazepine (PBD) payload. The potent payload binds to DNA minor groove with little distortion, remaining less visible to DNA repair mechanisms. This ultimately results in cell cycle arrest and tumor cell death.The U.S. Food and Drug
More news about: ADC Therapeutics SA
Dec 03, 2025, 05:00 ET MEXC Appoints Vugar Usi as Chief Operating Officer to Accelerate Global Growth and Redefine User-First Crypto Trading Experience
innovation, rapid expansion, and sustained momentum across international markets. What truly sets the company apart for me is its deep, mission-driven DNA. As the new Chief Operating Officer, my focus is not on incremental change, but on fundamentally raising the standard for what a global, retail-first
More news about: MEXC
Dec 03, 2025, 05:00 ET MEXC Appoints Vugar Usi as Chief Operating Officer to Accelerate Global Growth and Redefine User-First Crypto Trading Experience
innovation, rapid expansion, and sustained momentum across international markets. What truly sets the company apart for me is its deep, mission-driven DNA. As the new Chief Operating Officer, my focus is not on incremental change, but on fundamentally raising the standard for what a global, retail-first
More news about: MEXC
Dec 02, 2025, 12:04 ET DNA&STONE NAMES JESS WATTS FIRST-EVER CHIEF STRATEGY OFFICER
more about DNA&STONE, please visit www.dnaandstone.com.About DNA&STONEDNA&STONE
More news about: DNA&STONE